Prediction: New Reason Lilly Stock Could Still Rise
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Zero Based Budgeting connects each expense to a goal, making progress measurable and budgets purpose-driven every month.
28,655 articlesEli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Apple posted a record iPhone revenue quarter and strong customer satisfaction, yet the market remains divided on how ...
DeCaro Auctions unveils a broadened leadership slate as it targets international expansion of its luxury real estate ...
Mortgage lenders are pruning a sprawling web of loan-origination integrations as outages and delays threaten closings...
A major AI and cloud deal is flanking SpaceX's IPO, potentially nudging investor sentiment. This article breaks down ...
NVIDIA and Micron delivered standout AI hardware results, but investors reacted differently as the AI demand mix shif...
Microsoft is riding a fast-growing AI wave, but its stock hasn’t followed the surge. Here’s how analysts and models v...
U.S. stocks rise as inflation remains stubborn, oil prices jump, and growth slows. The Nasdaq Composite leads gains a...
The Department of Justice confirmed an active antitrust inquiry into the U.S. beef industry, targeting major meatpack...
NVIDIA stock sits at a crossroads as AI-driven demand and hyperscale spending shape a potential move toward $300. Ana...
Meta Platforms faces a bold forecast that its market value could hit $2 trillion by 2027, even as the company spends ...
A board director at Veracyte sold shares after a substantial stock run. This guide shows you how to interpret insider...